Skip to content

A study to compare the effectiveness of intrapleural streptokinase with conventional treatment in children with empyema.

Intrapleural streptokinase adjunct to conventional treatment vs conventional treatment in paediatric empyema-An open labelled randomized control trial. - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097393
Enrollment
60
Registered
2025-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J869- Pyothorax without fistula

Interventions

Intervention1: Intrapleural Streptokinase: Intrapleural streptokinase administered as adjunct to conventional management . Dose - 15000 IU /kg diluted in 50 ml normal saline for 3 days Control Interv

Sponsors

Shubham Rastogi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with definitive diagnosis of empyema with visible puson diagnostic pleural tap and/or septations /loculations on ultrasound of chest.

Exclusion criteria

Exclusion criteria: a. Any history of coagulopathy b. Confirmed case of pneumothorax or bronchopleural fistula c. Any history of head trauma in preceeding 2 weeks . d. Any history of recent major surgery .

Design outcomes

Primary

MeasureTime frame
Reduction in pleural fluid volume and improvement in clinical condition (resolution of fever , respiratory distress , and radiological clearance on chest x ray ).Timepoint: Day 7 and at completion of hospital stay.

Secondary

MeasureTime frame
Duration of hospital stay .Timepoint: 4 weeks;Duration of chest tube drainageTimepoint: 3 weeks.;Requirement of surgical intervention ( decortication )Timepoint: 4 weeks.;Adverse effects or complications related to streptokinaseTimepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Srikanta Basu

Lady hardinge medical college

srikantabasu@gmail.com9818291595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026